Arcensus

Arcensus is a privately held, revenue-generating diagnostics company focused on making whole genome sequencing a standard tool for physicians. It operates a CAP-accredited and ISO-certified laboratory, offering end-to-end services from sample logistics to clinical interpretation and reporting, primarily for rare genetic diseases. The company leverages a distributor-partner network to scale its reach and emphasizes data security and periodic data re-evaluation as key differentiators. Its strategic position aims to capitalize on the growing integration of genomics into routine clinical care.

Clinical-grade Whole Genome Sequencing (WGS) and Whole Exome Sequencing (WES) with integrated bioinformatics and a proprietary re-evaluation system that updates patient reports as genomic knowledge evolves.

Arcensus competes in the crowded clinical genomics space against large commercial labs (e.g., Quest, Labcorp), specialized rare disease diagnostics firms, and academic medical centers. Its differentiation hinges on its comprehensive WGS focus, CAP/ISO accreditations, unique data re-evaluation service, and strong emphasis on physician-oriented reporting and data security.